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Abstract
Strains of HSV-1 have been noted to vary in their pathogenesis. We compared the replication of
strains KOS and McKrae in mice by two routes of infection, ocular and vaginal. Peripheral
replication of KOS was similar (cornea) or attenuated over time (vagina) compared with McKrae;
however, McKrae replicated in the nervous system to significantly higher levels than KOS after
inoculation by either route. Host genetic background strongly influenced the capacity for virus
entry into the nervous system from the vagina. KOS and McKrae replicated equivalently after
intracranial inoculation, indicating that McKrae’s pathogenic phenotype is linked to
neuroinvasiveness rather than neurovirulence.
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Herpes simplex virus 1 (HSV-1) is a herpesvirus belonging to the neurotropic
Alphaherpesvirinae subfamily (Roizman et al., 2012). HSV-1 infections can be
asymptomatic or cause cold sores, corneal ulcerations, and rare but life-threatening
encephalitis (Roizman et al., 2012). In addition, HSV-1 causes a growing proportion of HSV
genital infections (Bhattarakosol et al., 2005; Gilbert et al., 2011; Horowitz et al., 2011;
Kortekangas-Savolainen and Vuorinen, 2007; Pena et al., 2010; Pereira et al., 2012; Smith
and Roberts, 2009) which also can be asymptomatic, result in painful ulcerative lesions, or
sometimes cause aseptic meningitis or autonomic dysfunction (Gupta et al., 2007). Initial
HSV-1 infections at mucosal surfaces rapidly spread into sensory neurons, where the virus
remains latent until it receives a reactivation stimulus. Numerous strains of HSV-1 have
been isolated that vary in their virulence (Bergstrom et al., 1990; Dix et al., 1983; Hill et al.,
1987). One HSV-1 strain, KOS (Smith, 1964), was originally isolated from a cold sore and
has been passaged 12 times in tissue culture. KOS is frequently used to investigate HSV-1
gene function and pathogenesis (Schaffer et al., 1973), and has been described as less
virulent than a number of other HSV-1 strains (Luker et al., 2006; Perng et al., 2002;
Strelow and Leib, 1995). Another HSV-1 strain, McKrae, was isolated from a patient with
herpes simplex keratitis (Williams et al., 1965), and passaged an unknown number of times
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in tissue culture. McKrae undergoes spontaneous or induced reactivation at a higher
frequency and is among the most virulent HSV-1 strains in animal models (Hill et al., 1987;
Perng et al., 2002; Sawtell et al., 1998; Strelow et al., 1994).
Inter-strain differences in HSV-1 peripheral replication and virulence have been observed in
animal models. HSV-1 strain KOS replicates as well as or better than strain 17syn+ or
McKrae in the snout or cornea of mice (Sawtell et al., 1998; Strelow et al., 1994), although
bioluminescence imaging indicates KOS is attenuated relative to 17syn+ and McKrae over
time after inoculation in these sites (Luker et al., 2006). After injection into the footpad or
anterior chamber, KOS reaches the nervous system similarly to 17syn+ or H129,
respectively, but is dramatically reduced in its capacity to disseminate in neural tissue
(Thompson et al., 1986; Archin and Atherton, 2002) and to cause lethal infection after
intracranial (i.c.) inoculation compared with other strains (Dix et al., 1983). HSV-1 strain
McKrae, in contrast to KOS, is highly virulent following corneal inoculation of rabbits and
mice (Perng et al., 1995). KOS and McKrae appear to replicate efficiently in the mucosa
after intravaginal (i.vag.) inoculation in some studies (Inagaki-Ohara et al., 2000; Zheng et
al. 2012) but not others (Murphy et al., 2003), and neither appears to reach the nervous
system (Inagaki-Ohara et al., 2000; Zheng et al., 2012). However, a direct comparison of
these two HSV-1 strains by the genital route has not been reported. In one study comparing
i.vag. inoculation of HSV-1 strain 17syn+ to strain IES, a thymidine kinase-deficient mutant
(Muller et al., 1979), 17syn+ replicated for a prolonged period in the genital mucosa, caused
severe vaginitis, and spread more readily to the nervous system (Podlech et al., 1996). Taken
together, these observations suggest strain- and route-dependent differences in HSV-1
neuroinvasiveness.
To directly test strain-dependent differences in pathogenesis during acute infection, we
compared the capacity of HSV-1 strains KOS and McKrae to replicate and spread in mice
after inoculation by two routes relevant to human infection, the cornea and the genital tract.
After inoculation of C57BL/6 (B6) mice via the cornea as previously described (Morrison
and Knipe, 1994), KOS and McKrae replicated to a similar extent in the corneal epithelium
through 4 d post-infection (Fig. 1A). Subsequently, KOS replicated to nearly the same
extent as McKrae in the trigeminal ganglia; however, KOS titers in the brainstem and brain
were reduced 100-fold compared with McKrae (Fig. 1B). To determine the effect of host
genetic background on KOS attenuation, we repeated the experiment in BALB.B mice
which share the MHC locus of B6 mice but diverge with regard to non MHC-linked genes.
KOS replicated as well as or slightly better than McKrae over time in the corneal epithelium
of BALB.B mice (Fig. 1C), but again was markedly attenuated for replication in the nervous
system (Fig. 1D).
To distinguish whether the persistent neural attenuation of KOS reflects a reduced capacity
to spread into the central nervous system (CNS) or to replicate in neural tissue, mice were
infected i.c. with strains KOS or McKrae as previously described (Korom et al., 2008).
Replication of KOS and McKrae was equivalent in B6 (Fig. 2A) and BALB.B (Fig. 2B)
mice at 24 h post-infection, and both viruses replicated to higher titers in BALB.B mice than
B6 mice. To ensure that virus titers had not simply reached their maximum, we also
examined titers of the viruses 48 h post-infection. Both strains showed a similar increase in
titer at 48 h. These data suggest that the attenuation of KOS after corneal inoculation
represents a defect in neuroinvasiveness rather than in growth in neural tissue.
We also infected mice i.vag. as previously described (Morrison et al., 1998) with KOS and
McKrae. In B6 mice, KOS and McKrae replicated to similar extents in the vaginal mucosa
(Fig. 3A), except for a transient spike in the day 4 titers of McKrae-infected mice. Only
McKrae, however, caused significant inflammation of the external genitalia (Fig. 3B), and
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weight loss (data not shown). KOS was not detected in neural tissue and McKrae was
detected only in rare instances (Fig. 3C). In BALB.B mice, KOS and McKrae replicated to
nearly the same extent in the vaginal mucosa over the first 2 d post-infection (Fig. 3D).
From 3 to 5 d post-infection, however, the titer of KOS fell to an undetectable level, while
replication of McKrae declined more slowly. McKrae also provoked genital inflammation
which steadily grew more severe (Fig. 3E). In contrast, mice infected i.vag. with KOS
showed no signs of genital disease. Body weight of McKrae-infected mice also declined an
average of 15% by 7 d post-infection, whereas mice infected with KOS gained weight (data
not shown). McKrae replicated robustly in spinal cord, brainstem, and brain of BALB.B
mice, but KOS was below the level of detection in nearly all cases (Fig. 3F). Thus, McKrae
caused peripheral disease and spread to the CNS of mice after i.vag. inoculation much more
readily than KOS.
HSV-1 strains KOS and McKrae are examples of strains with low and high reactivation
potential, respectively, in animal models of ocular infection (Berman and Hill, 1985; Gerdes
and Smith, 1983; Gordon et al., 1990; Hill et al., 1987; Laycock et al., 1991; Sawtell et al.,
1998; Shimeld et al., 1990; Strelow et al., 1994; Willey et al., 1984). Here we demonstrate
by direct in vivo comparison that HSV-1 strains KOS and McKrae also differ in
neuroinvasiveness or capacity to spread into the CNS after ocular or vaginal infection of
mice. The differences in replication capacity in vivo were not reproduced in primary mouse
fibroblast, brainstem astrocyte, or brainstem neuron cultures (data not shown), suggesting
factors in the intact host restrict KOS replication and spread. Importantly, because B6 and
BALB.B mice share the same H-2 haplotype, the greater attenuation of KOS compared with
McKrae that we observed in B6 mice indicates a non MHC-linked host resistance
mechanism.
Replication of McKrae resembled that of KOS in the vaginal mucosa of B6 mice, except for
a transient upturn on day 4 post-infection, which is typically observed with virulent strains
in the i.vag. model (Thebeau et al., 2007; Morrison 2008; Vagvala et al., 2009). This
increase may result from virus infection of newly regenerated vaginal epithelial cells, or
virus returning from the dorsal root ganglia to the mucosa and amplifying the infection.
Further investigation will be needed to distinguish between these possibilities. We made the
novel observation that KOS replication is comparatively restricted in the vaginal mucosa of
BALB.B mice, primarily after day 2 post-infection. This attenuation may represent
differential sensitivity of KOS to type I IFNs (Murphy et al., 2003) or substance P (Svensson
et al., 2005) but is more likely related to innate cellular immune responses such as
neutrophils or NK T cells (Milligan et al., 2001; Ashkar and Rosenthal, 2003). Conceivably,
HSV-1 strain-dependent differences in chemokine production could elicit different types or
amount of inflammatory cell infiltrates in the mouse genital tract (Zheng et al., 2012).
Reduced capacity of KOS to counteract TLR2 or type I IFN signaling in the CNS (Kurt-
Jones et al., 2004; Wang et al., 2012) could also possibly play a role in its relative neural
attenuation.
Two lines of evidence from our study demonstrate that KOS has a defect in
neuroinvasiveness and/or neural spread rather than neurovirulence. First, KOS replicated to
a similar extent as McKrae after direct i.c. inoculation, indicating KOS has no inherent
defect for growth in the CNS; however, KOS was not detected in the nervous system of
most mice after i.vag. inoculation. Second, although KOS and McKrae replicated in the
cornea and spread from the cornea to the TG with approximately equal efficiency in B6
mice, McKrae spread from the TG to the CNS more aggressively than KOS. Our results
using the corneal and vaginal routes of infection, combined with previous results of footpad
inoculation (Dix et al., 1983; Thompson et al., 1986) suggest a universal deficit in KOS
neuroinvasiveness. Whether HSV-1 KOS enters the nervous system at a high frequency but
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does not replicate efficiently will be a subject of future investigation. Neuronal entry and
spread are determined in part by gE/gI (Dingwell et al., 1995), but many viral gene products
have been described as neurovirulence or pathogenic factors and may have a role in
promoting replication in neurons. The viral determinants that contribute to McKrae’s in vivo
phenotypes are largely unknown. One study comparing wildtype McKrae to a gK mutant
suggested a potential role for gK in neuroinvasiveness (David et al., 2008); however, a
profound reduction in corneal spread observed with this mutant complicated the
interpretation. Additional studies comparing a wild-type HSV-1 strain to gB, ICP34,5, or
uracil DNA glycosylase in vivo (Bergstrom et al, 1992; Bower et al., 1999; Pyles and
Thompson, 1994), suggest roles for these gene products in neuroinvasion, Sequence
analyses of the KOS and McKrae genomes (Macdonald et al. 2012a; Macdonald et al.
2012b; Watson et al., 2012) indicate non-synonymous variations in these genes and many
others, some of which are expected to delineate the molecular basis for differences in the
pathogenicity of these two HSV-1 strains.
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Corneal infection with HSV-1 McKrae results in higher titers in the nervous system than
HSV-1 KOS. KOS or McKrae was inoculated onto the scarified corneas of (A and B) B6
mice at 1×106 pfu per eye, or (C and D) BALB.B mice at 2×105 pfu/eye. (A and C) Titer of
virus shed in tear film over time post-infection. (B and D) Titer of virus in nervous system
tissues was determined 5 d (B6) or 4 d (BALB.B) post-infection. Values are the geometric
means ± SEM of 5 to 6 mice per group (B6) or 7 mice per group (BALB.B) and are the
combined results of two independent experiments for each mouse strain. Dashed lines
represent limit of detection in the assay. *, P = 0.0125; ***, P = 0.0006 to <0.0001.
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Intracranial inoculation yields equivalent titers of HSV-1 KOS and McKrae. Groups of 5 to
7 mice were inoculated i.c. with 1×103 pfu of virus. Values are the geometric mean titers ±
SEM of virus detected in brain tissue of (A) B6 mice and (B) BALB.B mice 24 h and 48 h
after infection, and are the combined results of two independent experiments each. The
increase from 24 to 48 h was statistically significant (P = 0.0265 to 0.0001).
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HSV-1 McKrae is more virulent than KOS after intravaginal infection. KOS or McKrae was
inoculated i.vag. into (A–C) B6 mice at 2×106 pfu per mouse, or (D–F) BALB.B mice at
1×106 pfu/mouse. (A and D) Titer of virus shed from the vaginal mucosa over time post-
infection. (B and E) Genital disease scores, determined in masked fashion based on the scale
0, normal; 1 slight erythema and edema; 2 marked erythema and edema; 3, presence of
lesions. (C and F) Titer of virus in nervous system tissues 7 d post-infection. Values are the
geometric mean + SEM of 7 to 8 B6 or BALB.B mice per group and are the combined
results of two independent experiments. Dashed lines represent limit of detection in the
assay. *, P = 0.031 to 0.0112; **, P = 0.0052 to 0.004; ***, P = 0.0002 to <0.0001.
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